Skip to main navigation Skip to search Skip to main content

A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data

  • P Gimsing
  • , Torben Plesner
  • , H Nahi
  • , H Lokhorst
  • , M-L Valentin
  • , S Lisby
  • , PG Richardson

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Original languageEnglish
Publication date8. Dec 2011
Publication statusPublished - 8. Dec 2011
Event53th ASH Annual Meeting -
Duration: 8. Dec 2011 → …

Conference

Conference53th ASH Annual Meeting
Period08/12/2011 → …

Cite this